LRMR

$4.15+0.14 (+3.49%)

After Hours$4.15+0.00 (+0.00%)· Last close May 6

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform.

Overview Intraday ResearchPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO